首页> 外文OA文献 >PCN95 COST-EFFECTIVENESS OF SEROTONIN-TYPE 3 RECEPTOR ANTAGONISTS FOR CHEMOTHERAPY-INDUCED EMESIS IN NON SMALL CELL LUNG CANCER PATIENTS RECEIVING CISPLATIN-BASED CHEMOTHERAPY

【2h】

PCN95 COST-EFFECTIVENESS OF SEROTONIN-TYPE 3 RECEPTOR ANTAGONISTS FOR CHEMOTHERAPY-INDUCED EMESIS IN NON SMALL CELL LUNG CANCER PATIENTS RECEIVING CISPLATIN-BASED CHEMOTHERAPY

机译：非小细胞肺癌患者接受基于鞘磷脂的化学疗法的化疗引起的呕吐的血清素3型受体拮抗剂PCN95的成本效益

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Colayco DC; Hay J;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled trial. [J] . Grunberg SM, Rolski J, Strausz J The lancet oncology . 2009,第6期

机译：甲磺酸神经舒张素1（NK1）受体拮抗剂casopitant甲磺酸盐在预防以顺铂为基础的高度致呕性化疗患者化疗引起的恶心和呕吐方面的功效和安全性：一项随机，双盲，安慰剂对照试验。
2. Efficacy of Ginger in Ameliorating Acute and Delayed Chemotherapy-Induced Nausea and Vomiting Among Patients With Lung Cancer Receiving Cisplatin-Based Regimens: A Randomized Controlled Trial [J] . Xiangfeng Li, Ying Qin, Wei Liu, Integrative cancer therapies. . 2018,第3期

机译：生姜对接受顺铂为基础的肺癌患者缓解急性和延迟化疗引起的恶心和呕吐的疗效：一项随机对照试验。
3. Chemotherapy-Induced Emesis in Elderly Cancer Patients: The Role of 5-HT(3)-Receptor Antagonists in the First 24 Hours. [J] . Aapro M, Johnson J Gerontology: International Journal of Experimental and Clinical Gerontology . 2005,第5期

机译：在老年癌症患者中化疗诱导的呕吐：在最初的24小时内5-HT（3）受体拮抗剂的作用。
4. A side-effects mapping model in patients with lung, colorectal and breast cancer receiving chemotherapy [C] . Mazzocco Thomas, Hussain Amir 2011 IEEE 13th International Conference on e-Health Networking, Applications and Services . 2011

机译：肺癌，结直肠癌和乳腺癌患者接受化疗的副作用映射模型
5. Stability of Symptom Clusters in Patients With Lung Cancer Receiving Chemotherapy [D] . Russell, Jacquelyn 2019

机译：肺癌患者化疗后症状群的稳定性
6. The Cardiac Markers and Oxidative Stress Parameters in Advanced Non-Small Cell Lung Cancer Patients Receiving Cisplatin-Based Chemotherapy [O] . Urszula Demkow, Beata Biatas-Chromiec, Anna Stelmaszczyk-Emmel, 2011

机译：晚期非小细胞肺癌接受顺铂化疗的患者的心脏标志物和氧化应激参数
7. Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy [O] . Wichit Arpornwirat, Istvan Albert, Vincent L. Hansen, 2009

机译：第2阶段试验结果与新型神经喹啉-1受体拮抗剂潜水剂与ondansetron和地塞米松组合用于预防化疗诱导的恶心，癌症患者患者接受中度胰腺化疗的癌症患者

PCN95 COST-EFFECTIVENESS OF SEROTONIN-TYPE 3 RECEPTOR ANTAGONISTS FOR CHEMOTHERAPY-INDUCED EMESIS IN NON SMALL CELL LUNG CANCER PATIENTS RECEIVING CISPLATIN-BASED CHEMOTHERAPY

著录项

引文网络

相似文献

相关主题

期刊订阅